National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
    Posted: 11/09/2005
Page Options
Print This Page
E-Mail This Document
Find News Releases

  Search For:  
   
  Between these dates:

 
      
      
spacer image
            

BenchMarks
BenchMarks

    Volume 7, Issue 4

Private-Public Partnerships in Cancer Vaccine Research

Media Resources
Noticias

Understanding Cancer Series

Visuals Online
An NCI database of cancer-specific scientific and patient care-related images, as well as general biomedical and science-related images and portraits of NCI directors and staff.

Video PressPacks
[The NewsMarket]

Video Asset Library
[The NewsMarket]

B-Roll Footage

Radio Broadcasts

Entertainment Resources
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

caBIG: Connecting the Cancer Community

Past Highlights
Entertainment Resources
Cancer on TV: NBC-TV’s “ER”

Topic: Breast Cancer and BRCA Gene
Original Air Date - October 6, 2005: “Man with No Name”
Original Air Date - October 20, 2005: “Wake Up”

A Jewish, unmarried woman in her early-30s comes into the ER and informs the doctors that she recently tested positive for a BRCA gene mutation. The presence of the BRCA (short for BReast CAncer) mutation, along with a family history of breast and/or ovarian cancer, makes some women more susceptible to developing breast and ovarian cancers. However, not every woman in such families carries this mutation, and most women do not need to be tested.

The initial reason for her visit to the ER was side effects from some alternative medical treatment. Complementary and alternative medicine options are forms of treatment used in addition to (complementary) or instead of (alternative) standard treatments. Clinical trials are studies that are conducted to test how well these and other medical approaches work in people.

The physician (Abby) explains that her patient may be a candidate for prophylactic (preventive) mastectomy, which is the surgical removal of one or both breasts in an effort to prevent or reduce the risk of breast cancer. Prophylactic mastectomy may be an option for a woman whose mother, sister, or daughter had breast cancer, especially if they were diagnosed before age 50 and are of Ashkenazi Jewish descent (generally Eastern European Jews).

Like Abby’s patient, many women hesitate to seek treatment because they feel overwhelmed, afraid and alone. Other worries include not being able to find a spouse or being able to lactate because of her physical defects. These are common feelings that people diagnosed with cancer and their families may encounter. Cancer support groupsare one way patients can meet others and work through ways to cope with their conditions.

At the close of the episode, Abby also decides to have her first mammogram.

For more information about the BRCA gene, visit: http://www.cancer.gov/cancertopics/factsheet/Risk/BRCA

For more general information on breast cancer, visit: http://www.cancer.gov/cancertopics/types/breast

 

Back to Top


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov